Markets:

Overview

News

Currencies

International

Treasuries

Arrowhead Pharmaceuticals, Inc. - Common Stock (NQ:ARWR)

82.76 +0.13 (+0.16%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arrowhead Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Insights Ahead: Arrowhead Pharma's Quarterly Earnings ↗

May 09, 2025

Via Benzinga

Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases ↗

March 10, 2025

Arrowhead's ARO-C3 cut C3 levels by up to 89% and proteinuria by 41% in a Phase 1/2 trial. Additional results will be presented at a 2025 medical meeting.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 14, 2025

Via Benzinga

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

A Look Ahead: Arrowhead Pharma's Earnings Forecast ↗

November 25, 2024

Via Benzinga

Earnings Scheduled For February 10, 2025 ↗

February 10, 2025

Via Benzinga

Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗

December 01, 2024

8 mid-cap stocks saw impressive gains last week. Archer, Scholar Rock, Arrowhead, Iris Energy, Hims & Hers, SoundHound, Joby Aviation, and Urban Outfitters all performed well.

Via Benzinga

Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗

December 01, 2024

Top performers last week: RIVN, RKLB, SRPT, EXAS, ESTC, ULTA, MRNA, RL, CPRT, SNAP. Any in your portfolio? Citigroup raises price target on ULTA and SNAP.

Via Benzinga

Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday ↗

November 27, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On? ↗

November 26, 2024

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global licensing and collaboration agreement with Sarepta Therapeutics Inc. (NASDAQ: SRPT)....

Via Benzinga

J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday ↗

November 26, 2024

Via Benzinga

Arrowhead Launches 25% On A Massive Licensing Deal With Sarepta ↗

November 26, 2024

The deal focuses on four clinical-stage drugs, three preclinical assets and a potential five new targets.

Via Investor's Business Daily

Earnings Scheduled For November 26, 2024 ↗

November 26, 2024

Via Benzinga

Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up ↗

October 18, 2024

The company is working on treatments for forms of muscular dystrophy, and is taking on some of the biggest names in pharma.

Via Investor's Business Daily

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q3 2024 ↗

August 08, 2024

ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday ↗

July 05, 2024

Via Benzinga

Topics Stocks

What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients ↗

July 05, 2024

A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.

Via Investor's Business Daily

Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025 ↗

June 28, 2024

Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.

Via InvestorPlace

Why Arrowhead Pharmaceuticals (ARWR) Stock Is Seeing Blue Skies ↗

June 24, 2024

Arrowhead Pharmaceuticals shares are trading higher by more than 6% during Monday's session. The company announced that it presented preclinical data on ARO-INHBE.

Via Benzinga

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More ↗

June 24, 2024

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

Via Benzinga

Why Is Arrowhead Pharmaceuticals Stock Trading Higher On Monday? ↗

June 03, 2024

Arrowhead Pharmaceuticals announced Phase 3 PALISADE study results showing significant triglyceride reduction in familial chylomicronemia syndrome patients treated with plozasiran.

Via Benzinga

Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗

June 03, 2024

Via Benzinga

Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025 ↗

May 14, 2024

These stocks to buy are expected to double by 2025 and could turn mundane market returns into something bigger with a willingness to bet.

Via InvestorPlace

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 10, 2024

Via Benzinga

ARWR Stock Earnings: Arrowhead Pharma Misses EPS for Q2 2024 ↗

May 09, 2024

ARWR stock results show that Arrowhead Pharma missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment ↗

May 02, 2024

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses...

Via Benzinga

The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024 ↗

April 05, 2024

With risk-on sentiment in place, investors may be looking for the most undervalued Russell 2000 stocks to buy in April.

Via InvestorPlace

NetApp, Zoom Video And 2 Other Stocks Insiders Are Selling ↗

April 04, 2024

The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

7 Biotech Stocks to Buy as Sector Rotation Ramps Up ↗

March 13, 2024

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.